Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05233566
PHASE3

Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial

Sponsor: Washington University School of Medicine

View on ClinicalTrials.gov

Summary

This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2022-04-25

Completion Date

2023-03-08

Last Updated

2026-08-21

Healthy Volunteers

No

Interventions

DRUG

Ketamine

NMDA antagonist

DRUG

Normal saline

IV fluid acting as a placebo

Locations (1)

Washington University School of Medicine

St Louis, Missouri, United States